Vitality Biopharma Announces Corporate Updates and Completion of an SEC Examination
21 nov. 2018 07h00 HE
|
Vitality Biopharma, Inc
Company appoints two new directors including the Hon. Edward Feighan as new Chairman of the Board LOS ANGELES, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO)...
Vitality Biopharma Receives $8.5 Million Common Stock Financing
23 oct. 2018 07h00 HE
|
Vitality Biopharma, Inc
Financing to support company at least into 2020 and for the initiation of multiple Phase 2 clinical trials LOS ANGELES, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO)...
Vitality Biopharma Announces Neural Repair Treatment Patent Filings
03 oct. 2018 07h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma Scientific Co-Founder to Present Recent Data at CannMed Medical Conference in Los Angeles
13 sept. 2018 06h30 HE
|
Vitality Biopharma, Inc
LOS ANGELES, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...
Vitality Biopharma THC Prodrug VBX-100 Demonstrates Positive Safety Results
21 août 2018 06h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development Program
20 juin 2018 08h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, June 20, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Sponsors Clinical Research Forum on Ending Opioid Epidemic
05 juin 2018 09h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma to Present at the 8th Annual LD Micro Invitational
30 mai 2018 09h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, May 30, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Vitality Biopharma Discovers and Patents Use of Cannabinoids for C.diff-Associated Diarrhea and Colitis
10 mai 2018 08h30 HE
|
Vitality Biopharma, Inc
- Vitality’s GI-targeted VBX-100 THC compound to be investigated as treatment of recurrent C. difficile infections LOS ANGELES, May 10, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc....
Vitality Biopharma Launches Canadian Subsidiary Focused on Cannabinoid Genetics R&D
05 avr. 2018 09h00 HE
|
Vitality Biopharma, Inc
-Wholly-owned subsidiary to enable access to best available cannabinoid compounds in a federally-compliant manner and facilitate key collaborative research programs LOS ANGELES, April 05, 2018 ...